This inventor holds 1 USPTO granted patent. Top assignee: University of South Florida. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Ruizhi Wu
Introduction
Ruizhi Wu is a notable inventor based in Tampa, Florida. He has made significant contributions to the field of chemistry, particularly in the synthesis of optically pure heterocyclic compounds. His work has implications for the development of new anti-HIV and anticancer agents.
Latest Patents
Wu holds a patent for the "Formation of cyclopentene nitro-ester and derivatives." This patent discloses a method of synthesizing new optically pure heterocyclic compounds using Pd(0) catalyzed intramolecular cyclizations. The compounds he has developed, including analogs of cyclopentanes like isoxazoline-2-oxide and furan, have shown potential as anti-HIV and anticancer agents. His innovative approach allows for the preparation of optically pure compounds starting from a meso-diol without the use of chiral ligands at any stage of the synthesis. The stereochemical outcome of the product, achieving greater than 99% enantiomeric excess, is influenced by desymmetrization catalyzed by lipase and the stereoselective nature of the palladium-catalyzed transformations.
Career Highlights
Wu is affiliated with the University of South Florida, where he continues to advance his research in chemistry. His work has garnered attention for its potential applications in pharmaceuticals and therapeutic development.
Collaborations
Some of his notable coworkers include Alberto Van Olphen and Kirpal Singh Bisht. Their collaborative efforts contribute to the innovative research environment at the University of South Florida.
Conclusion
Ruizhi Wu's contributions to the field of chemistry, particularly through his patent on cyclopentene nitro-esters, highlight his role as an influential inventor. His work not only advances scientific knowledge but also opens new avenues for medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
